LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 33 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,976 | +1.6% | 4,000,000 | 0.0% | 0.04% | +5.9% |
| Q4 2022 | $3,914 | -99.8% | 4,000,000 | +100.0% | 0.03% | +47.8% |
| Q3 2022 | $1,945,000 | -0.2% | 2,000,000 | 0.0% | 0.02% | +9.5% |
| Q2 2022 | $1,949,000 | -0.3% | 2,000,000 | 0.0% | 0.02% | +16.7% |
| Q1 2022 | $1,955,000 | -3.0% | 2,000,000 | 0.0% | 0.02% | 0.0% |
| Q4 2021 | $2,016,000 | -0.1% | 2,000,000 | 0.0% | 0.02% | -18.2% |
| Q3 2021 | $2,019,000 | +1.9% | 2,000,000 | 0.0% | 0.02% | +10.0% |
| Q2 2021 | $1,982,000 | -91.9% | 2,000,000 | -91.5% | 0.02% | -91.8% |
| Q1 2021 | $24,392,000 | +19.2% | 23,500,000 | +9.3% | 0.24% | +4.3% |
| Q4 2020 | $20,467,000 | +140.4% | 21,500,000 | +130.3% | 0.24% | +117.6% |
| Q3 2020 | $8,515,000 | – | 9,337,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CANYON CAPITAL ADVISORS LLC | 40,000,000 | $38,988,000 | 1.44% |
| Penn Mutual Asset Management, LLC | 1,204,000 | $1,174,000 | 1.36% |
| TFG Asset Management GP Ltd | 21,600,000 | $21,148,000 | 0.96% |
| PALISADE CAPITAL MANAGEMENT, LP | 10,006,000 | $9,832,000 | 0.23% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 11,645,000 | $11,431,000 | 0.22% |
| OAKTREE CAPITAL MANAGEMENT LP | 20,353,000 | $19,882,000 | 0.21% |
| Wellesley Asset Management | 2,304 | $2,245,000 | 0.15% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 10,000,000 | $9,719,000 | 0.12% |
| SSI INVESTMENT MANAGEMENT LLC | 2,000,000 | $1,942,000 | 0.11% |
| Cutler Capital Management, LLC | 300,000 | $291,000 | 0.10% |